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Abstract
Objective
To identify trends of patients’ urinary and sexual dysfunctions from a clinical and psychologi-
cal perspective and understand whether sociodemographic and medical predictors could
differentiate among patients following different one-year longitudinal trajectories.
Methods
An Italian sample of 478 prostate cancer patients undergone Robot-Assisted Radical Pros-
tatectomy completed the EPIC-26 survey between July 2015 and July 2016 at the pre-hospi-
talization (T0), 45 days (T1) and 3 (T2), 6 (T3), 9 (T4), and 12 months (T5) after surgery.
Sociodemographic and clinical characteristics (age, BMI, diabetes, nerve-sparing proce-
dure) were also collected. Latent Class Growth Analysis was conducted separately for sex-
ual dysfunction and urinary incontinence EPIC-26 subscales. The association between
membership in the two longitudinal trajectories of urinary and sexual dysfunctions was
assessed by considering Chi-square test and its related contingency table.
Results
People who have a high level of urinary incontinence at T1 are likely to have a worse recov-
ery. Age, BMI and pre-surgical continence may affect the level of incontinence at T1 and the
recovery trajectories. Patients with low and moderate sexual problems at T1 can face a
moderate linear recovery, while people with high level of impotence immediately after sur-
gery may take a longer period to solve sexual dysfunctions. Age and the pre-surgical sexual
condition may impact the recovery. Finally, a great proportion of patients reported both
steady problems in sexual function and constant high levels of urinary incontinence over
time.
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Conclusions
This study highlights different categories of patients at risk who may be important to know in
order to develop personalized medical pathways and predictive models in a value-based
healthcare.
Introduction
Prostate cancer (PC) is diagnosed in over one million of people worldwide and almost 70%
of these cases occurred in the developed regions, where tumor detection and patients’ life
span are prolonged by advancement in treatments [1–3]. In fact, the 5-year survival was esti-
mated roughly 80–90% in most of the European countries, except those in Eastern Europe [4].
Therefore, cancer screening and new interventions have become increasingly wide in order
to successfully treat the disease, with less side-effects and improving patients’ quality of life.
According to the specific diagnosis, localized PCs are treated with radiotherapy, active surveil-
lance, and, above all, radical prostatectomy[5–7]. Despite all advancements in surgical and
radiant treatments, a recent study shows that, regardless any treatments, 90% of PC survivors
reported at least one physical impairment during the two-years post-diagnosis. Sexual, urinary
and bowel dysfunctions are the most common functional consequences after PC treatments
and they may persist for several years [8,9]. Compared to radiotherapy and active surveillance,
men who underwent robot-assisted radical prostatectomy (RARP) reported greater negative
side effects especially in the first 6 months from the surgery, even though there was a partial
recovery [10]. Sixty percent of men suffer from urinary incontinence and sexual problems
after surgery, that are often related to distress and fatigue symptoms. Following a variable-ori-
ented approach, several studies investigate the trend of these symptoms showing that patients
live longer with these side effects that deeply affect their quality of life for months after treat-
ment [11–15]. Nevertheless, it would be also important to identify different categories of PC
patients with different trends in recovery over time through a person-oriented approach that
can better display which kind of patients may have higher difficulties in the recovery of their
functional and psychological abilities. The person-oriented approach is a valid alternative to
the traditional variable-oriented methodology. The main analytic units of the variable-oriented
approach in health research are individual behaviours, health-related variables or construct
that may vary both within populations or over time [16]. In this kind of approach inter-indi-
vidual differences are rarely taken into account because they are considered random and negli-
gible [17]. On the contrary, the main assumption of the person-oriented approach is that
people are unique and that this uniqueness is measurable and worth knowing [18]. The main
analytic units of this approach are individuals or homogeneous subpopulations. From this per-
spective, inter-individual differences are meaningful and may be especially helpful to classify
individuals into distinct classes. Individuals belonging to the same class are similar to each
other while they are quite different from those classified in other classes. Examples of the
recent application of the person-oriented approach in health research are the identification of:
specific disease-prone personality types [19–21], longitudinal trajectories of neuropsychologi-
cal symptoms and cognitive decline in patients with Alzheimer’s diseases [22,23], longitudinal
pattern of change of lifestyle following acute coronary syndrome [24,25], and determinants of
trajectories of quality of life in people with type 2 diabetes [26]. Concerning prostate cancer,
Chambers et al. (2017) [27] applied a person-oriented approach to understand which factors
can affect different trajectories of patients’ recovery in Quality of Life, life satisfaction and
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psychological adjustment after different prostate cancer treatments, but nobody has already
focused the study research on physical function’s recovery in men with prostate cancer after
RARP surgery.
Clinical and sociodemographic characteristics may foreshadow the partial recovery of men
treated with RARP. Different studies showed that age, body mass index (BMI), and diabetes
may predict long-term post-operative incontinence after RARP [6,28]. While preservation of
the neurovascular bundle, age, and pre-surgery sexual condition were considered as positive
predictors of potency recovery following RARP [29–31]. Therefore, patients’ characteristics
play an important role in months after surgery: some pre-intervention sociodemographic and
clinical variables may influence and predict typical trend of patient’s recovery after robot-assis-
ted radical prostatectomy.
Physical dysfunctions are normally present during the months after surgery, highly affect-
ing patient’s survivorship and Quality of Life [12]. This new study perspective may help people
involved in the care process to better identify possible trajectories of physical and psychological
outcomes and predict which of the identified categories of patients would have greater difficul-
ties in their recovery.
The aim of this research study is to identify one-year trends of patients’ urinary and sexual
dysfunctions from a clinical and psychological point of view and understand whether sociode-
mographic (i.e., age) and medical variables (i.e., diabetes, BMI, nerve sparing, pre-surgery
scores of urinary incontinence and sexual dysfunction) could differentiate among patients fol-
lowing these different one-year longitudinal trajectories.
Materials and methods
Participants and procedure
An Italian sample of 478 men with localized PC who participated in the Value Based Project
and undergone RARP were enrolled at the European Institute of Oncology in Milan between
July 2015 and July 2016. Patients were included in the study if they: 1) were diagnosed with
localized PC, 2) were native Italian speakers, 3) referred to the Value Based Project and 4) had
not neurological or psychopathological problems. All eligible men were firstly asked to give
written informed consent and then were asked to complete the self-report EPIC-26 survey. At
the pre-intervention, sociodemographic and clinical characteristics were also collected, in par-
ticular age, BMI, presence or not of diabetes, PSA Class, Charlson Comorbidity Index, Gleason
Score, ASA Class, and preservation or not of the neurovascular bundle (nerve-sparing proce-
dure). Clinical characteristics were described in Table 1. They completed the EPIC-26 ques-
tionnaire at the pre-hospitalization (T0), 45 days (T1) and 3 (T2), 6 (T3), 9 (T4), and 12
months (T5) after RARP surgery. Since our aim was to study the trend of sexual and urinary
dysfunction after surgery and we saw that there was low outcomes variability among patients
before surgery, we excluded the baseline outcomes and run the analyses starting from T1, that
is 45 days after prostatectomy. Baseline outcomes (i.e., urinary incontinence and sexual dys-
function), alongside with sociodemographic and other clinical variables, were used to predict
patients’ membership in the identified longitudinal trajectories of urinary incontinence and
sexual dysfunction over time. All information and data were collected and analyzed by a multi-
disciplinary team of the Value Based Project. The Ethical Committee of the European Institute
of Oncology approved the study.
Measures
The Expanded Prostate Cancer Index Composite—Short Form EPIC-26 is the most used can-
cer-specific survey in Urology divisions to measure patient’s well-being [32–34]. The EPIC-26
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is a brief self-report scale, collecting medical and psychological information on urinary incon-
tinence, urinary irritation, bowel, sexual and hormonal dysfunction with a Likert-scale from 0
to 4 (or 5 in some items). Urinary Incontinence subscale consists of 4 items investigating leak-
ing urine, urinary control, number of pads used per day and overall urinary functioning, in
the last 4 weeks. Sexual dysfunction includes items on the ability to have an erection, ability to
reach an orgasm, quality of erections, frequency of erections, and overall sexual function, in
the last 4 weeks. Higher scores in subscales indicate worst medical conditions or higher prob-
lem perception. The EPIC-26 was administered at the pre-hospitalization (T0), 45 days (T1)
and 3 (T2), 6 (T3), 9 (T4), and 12 months (T5) after RARP surgery.
Age and BMI were collected for each participant at the pre-hospitalization. According to
the WHO Guidelines [35], a BMI cut-off of 27 divided the sample into two classes: patients
with a BMI< 27 were included in the “normal weight” class, while those with a BMI�27 were
included in the “overweight” class.
Diabetes and the preservation of the neurovascular bundle were included in medical vari-
ables. Three classes were identified: 1) patients undergone to radical prostatectomy with bilat-
eral nerve sparing procedure, 2) patients undergone to radical prostatectomy with unilateral
nerve sparing, and 3) patients undergone to radical prostatectomy with no nerve sparing.
Table 1. Sample clinical characteristics.
Sample (%)
Pre-surgery variables
Gleason Score
� 6 46.1
7 39.4
8 10.7
9–10 3.8
PSA Class
Less than 4 12.8
4–10 66.9
More than 10 20.3
ASA Class
1 18.7
2–3 81.3
BMI Class
Normal (< 27) 66.7
Overweight (�27) 33.3
Charlson Index
<1 72.8
�1 27.2
Surgery variables
Nerve Sparing
No 26.4
Unilateral 55.9
Bilateral 17.7
Post-surgery variables
Complications
No 89.3
Yes 10.7
https://doi.org/10.1371/journal.pone.0214682.t001
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Statistical analysis
To identify different longitudinal trajectories of patients with PC undergone RARP based on
their initial status and change over time in urinary incontinence and sexual dysfunction, we per-
formed a Latent Class Growth Analysis (LCGA) conducted separately for each of these two
EPIC-26 subscales. The LCGA is a flexible methodology to model patient longitudinal trajecto-
ries from unobserved subpopulations (i.e., latent trajectory classes) with patient variation in
growth parameters (e.g., intercept and slope) that are expressed with random effects. Another
advantage of this methodological approach is that predictors of longitudinal trajectory member-
ship could be identified within the LCGA framework by directly introducing these independent
variables in the model. This permitted to quantify the net effect of each predictor whist adjust-
ing for the other ones and, thus, to better and more validly identify the best predictors of longi-
tudinal trajectory membership (for a brief and clear overview of LCGA, see Jung & Wickrama,
2008)[36]. The LCGA approach has been efficiently adopted to identify trajectories of change
over time in quality of life, symptomatology, and adjustment to several types of illness, such as
heart failure [37], unipolar depression [38], low back pain [39], and breast cancer [40].
Non-linear LCGA consisting of intercept, slope and quadratic growth parameters were per-
formed with Mplus 8.2. Missing urinary incontinence and sexual dysfunction across waves were
handled using a robust full information maximum likelihood (FIML) estimation procedure. To
determine the number of classes to be extracted, we primarily considered the Lo-Mendell-Rubin
likelihood ratio test (LMR-LRT) following by other statistical considerations, such as a successful
convergence (i.e., no local maximum likelihood), high entropy value close to 1 (i.e., high precision
and certainty in the classification), and total count within each classes above 1% (i.e., absence of
classes with too few members). Specifically, the LMR-LRT compares the solution with k classes
with the solution with k-1 classes; statistically significant values indicate that the broader solution
(i.e., k classes) better fits the data than the more restricted k-1 classes solution. After determining
the number of classes to be extracted for the urinary incontinence and sexual dysfunction, clinical
and sociodemographic predictors of longitudinal change membership were introduced in the
unconditional LCGA models via multinomial logistic regression. We compared the reference
class (i.e., high levels of urinary incontinence or sexual dysfunction) with the other identified lon-
gitudinal trajectories to assess the discriminative power of each clinical and sociodemographic
predictor in differentiating among the identified longitudinal trajectories. Specifically, pre-surgery
urinary incontinence score, age, BMI (0 = BMI less than 27; 1 = BMI equal or greater than 27),
diabetes (0 = no diagnosis of diabetes; 1 = diagnosis of diabetes) were introduced as predictors to
explain membership in longitudinal trajectories of urinary incontinence. Pre-surgery sexual dys-
function score, age, and nerve sparing were introduced as predictors to explain membership in
longitudinal trajectories of sexual dysfunction. Because Mplus does not accommodate categorical
independent variables, nerve sparing was entered as two distinct dummy variables (i.e., unilateral
and bilateral nerve sparing; no nerve sparing was the reference category). In each model, the worst
longitudinal trajectory was chosen as the reference category in the multinomial regression model.
Finally, the association between membership in the two longitudinal trajectories of urinary
incontinence and sexual dysfunction was assessed by considering results of a Chi-square test
and its related contingency table.
Results
Identification of longitudinal trajectories of urinary incontinence
LCGA was performed on the urinary incontinence scores of the EPIC-26 measured at the five
time points of the present study. A five-class model with five different longitudinal trajectories
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was chosen because the LMR-LRT indicated that the five classes are significantly better than
four (p = .039) and better than six (p = .266). Moreover, this five-class solution also displayed
a high entropy level (.837) and total count within each class above 1% (min = 4.65%; max =
38.44%). Fig 1 reports the five identified longitudinal trajectories of urinary incontinence over
time.
Patients in the first class (38.44% of the total count) showed the lowest initial status of uri-
nary incontinence (intercept = 1.25, p< .001) and a moderate recovery over time (slope =
-0.29, p< .001; quadratic = 0.03, p< .001). We labeled this longitudinal trajectory as “Class
1”. As shown in Table 2, 51.4% of patients presented with biopsy Gleason score 6, while in
2.2% of cases was higher than 8. The majority of patients (67%) had a pre-surgical PSA
between 4 and 10, and 76.1% had an ASA score between 2 and 3. The Charlson Index was
lower than 1 in 78.4% of the sample. Moreover, 91.4% of patients who underwent RARP and
belonging to this Class had not post-surgical complications. The “Class 2” encompassed
26.44% of patients with moderate initial levels of urinary incontinence (intercept = 2.68, p<
.001) and a sudden decrease of symptomatology over time (slope = - 0.62, p < .001; qua-
dratic = 0.05, p< .001). Eighty-five percent of patients belonging to Class 2 had a Gleason
Score lower than eight, 73.1% of them had a PSA index varying between 4 and 10, and 84.2%
an ASA score of 2 or 3. Their Charlson Index was lower than 1 in 72.4% of the cases and 89.6%
of the Class 2 had not complications after surgery (see Table 2). The third class (18.32% of the
total count), labeled “Class 3”, was characterized by a moderate urinary incontinence at base-
line (intercept = 2.72, p < .001) and a moderate recovery over time (slope = - 0.27, p< .001;
quadratic = 0.02, p = .021). Almost 49% of patients presented with biopsy Gleason score 6,
while in 1.2% of cases was 9 or 10 (see Table 2). The majority of patients (60%) had a pre-surgi-
cal PSA between 4 and 10, and 83.5% had an ASA score between 2 and 3. The Charlson Index
was lower than 1 in 68.8% of the sample. Moreover, 88.8% of patients who underwent RARP
and belonging to Class 3 had not post-surgical complications. The “Class 4” included 12.14%
of patients with a high urinary incontinence at 45 after the RARP (intercept = 3.46, p< .001)
and a moderate recovery over time (slope = - 0.26, p < .001; quadratic = 0.02, p = .059).
Eighty-three percent of patients belonging to Class 4 had a Gleason Score lower than eight,
59.3% of them had a PSA index varying between 4 and 10, and 84.5% an ASA score of 2 or 3.
Their Charlson Index was lower than 1 in 71.2% of the cases and 88.1% of the Class 4 had not
Fig 1. The five identified longitudinal trajectories of urinary incontinence.
https://doi.org/10.1371/journal.pone.0214682.g001
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complications after surgery (see Table 2). The last class (4.65% of the total count) had the
worst initial status of urinary incontinence (intercept = 3.70, p< .001) with a flat and non-sig-
nificant linear and quadratic trajectory (linear slope = - 0.03, p = .403; quadratic slope = 0.00, p
= .758). This class could be labeled “Class 5”. As shown in Table 2, this Class showed a Gleason
Score of 6 in 35% and 7 in 40% of the cases, respectively. Seventy-five percent of the patients
belonging to Class 5 had a PSA index varying from 4 to 10, and 90% of them showed an ASA
score of 2 or 3. The Charlson index was higher than 1 in 55% of the cases and men of this Class
had post-surgical problems in 25% of the cases.
Sociodemographic and clinical predictors of longitudinal trajectories of
urinary incontinence
Then, the predictive role of clinical and sociodemographic variables to explain membership in
longitudinal trajectories of urinary incontinence was assessed through multinomial logistic
regression. Specifically, pre-surgery urinary incontinence score, age, BMI, and diabetes were
introduced in this model as predictors of longitudinal change membership.
Because “Class 5” was the worst longitudinal trajectory of urinary incontinence over time,
this class was chosen as the reference category in the multinomial regression model. Results
showed that more elderly patients (B = -0.09, OR = 0.92, p = .004) and higher levels of pre-sur-
gery incontinence (B = - 1.30, OR = 0.27, p = .003) had a lower chance to belong to “Class 2”
compared to “Class 5”. Moreover, compared to “Class 5”, “Class 4” was characterized by over-
weight or obese patients (B = 1.04, OR = 2.83, p = .035). More elderly patients (B = - 0.08,
OR = 0.92, p = .007) with higher levels of pre-surgery incontinence (B = - 2.27, OR = 0.10, p =
.015) had a lower likelihood of being included in “Class 1” than in “Class 5”. Finally, compared
to the worst longitudinal trajectory of urinary incontinence over time, prostate patients within
“Class 3” were younger (B = - 0.08, OR = 0.92, p = .025) and with less pre-RARP incontinence
(B = - 1.11, OR = 0.33, p = .007).
Diabetes was not helpful to distinguish between patients belonging to the five classes.
Table 2. Clinical variables in identified urinary clusters.
Clinical Variables Class 1 (%) Class 2 (%) Class 3 (%) Class 4 (%) Class 5 (%)
Gleason Score
� 6 51.4 42.5 48.8 39.0 35.0
7 35.5 42.5 40.0 44.0 40.0
8 10.9 7.5 10.0 13.6 25.0
9–10 2.2 7.5 1.2 3.4 0
PSA Class
Less than 4 14.6 7.5 18.8 11.9 10.0
4–10 67.0 73.1 60.0 59.3 75.0
More than 10 18.4 19.4 21.2 28.8 15.0
ASA Class
1 23.9 15.8 16.5 15.5 10.0
2–3 76.1 84.2 83.5 84.5 90.0
Charlson Index
<1 78.4 72.4 68.8 71.2 45.0
�1 21.6 27.6 31.2 28.8 55.0
Complications
No 91.4 89.6 88.8 88.1 75.0
Yes 8.6 10.4 11.2 11.9 25.0
https://doi.org/10.1371/journal.pone.0214682.t002
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Identification of longitudinal trajectories of sexual dysfunction
LCGA was performed on the sexual dysfunction scores over time. A three-class model with
three distinct longitudinal trajectories was chosen because the LMR-LRT indicated that the
three classes are significantly better than two (p< .001) and better than four (p = .404). More-
over, this three-class was also supported by a high entropy value (.913) and total count within
each class above 1% (min = 15.49%; max = 59.92%). Fig 2 reports these identified longitudinal
classes of change of sexual dysfunction over time.
Patients in the first class (24.59% of the total count) showed a medium initial level of sexual
dysfunctionality (intercept = 3.54, p< .001) and a moderate recovery over time (slope = - 0.18,
p< .001; quadratic = 0.01, p = .172). We labeled this class as “Class 1”. As shown in Table 3,
55.1% of patients presented with biopsy Gleason score 6, while in 44.9% of cases was between7
and 8. The majority of patients (71.2%) had a pre-surgical PSA between 4 and 10, and 77.6%
had an ASA score between 2 and 3. The Charlson Index was lower than 1 in 72.9% of the sam-
ple. Moreover, 91.5% of patients who underwent RARP and belonging to this Class had not
post-surgical complications. “Class 2” encompassed 59.92% of patients with the higher levels
of sexual impairment at baseline (intercept = 4.34, p< .001) and a flat and non-significant
recovery over time (slope = 0.02, p = .123; quadratic = - 0.01, p = .002). Almost eighty-two per-
cent of patients belonging to Class 2 had a Gleason Score lower than eight, 63.2% of them had
a PSA index varying between 4 and 10, and 84.2% an ASA score of 2 or 3. Their Charlson
Index was lower than 1 in 69.4% of the cases and 87.5% of the Class 2 had not complications
after surgery (see Table 3). The third class (15.49% of the total count), labeled “Class 3”, was
characterized by the lowest levels of sexual dysfunction at 45 days after the RARP (inter-
cept = 2.23, p< .001) and a moderate recovery over time (slope = - 0.11, p = .046; qua-
dratic = 0.01, p = .420). Patients belonging to Class 3 showed a biopsy Gleason score of 6 in
66.2%, 7 in 26.8% and 8 in 7% of the cases, respectively. Seventy-five% of patients had a PSA
index from 4 to 10 and an ASA score of 2 or 3. Eighty-six percent of patients had a Charlson
index lower than 1, while almost 93% percent had not complications after RARP (See Table 3).
Clinical predictors of longitudinal trajectories of sexual dysfunction
Then, the predictive role of clinical and sociodemographic variables to explain membership in
longitudinal trajectories of sexual dysfunction was evaluated through multinomial logistic
Fig 2. The three identified longitudinal trajectories of sexual dysfunction.
https://doi.org/10.1371/journal.pone.0214682.g002
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regression. Specifically, pre-surgery sexual dysfunction score, age, and nerve sparing were
introduced in this model as predictors of longitudinal change membership.
Because “Class 2” was the worst longitudinal trajectory of sexual dysfunction over time, this
class was chosen as the reference category in this multinomial regression model. Results showed
that more elderly patients (B = - 0.08, OR = 0.93, p = .004) and higher level of pre-surgery sexual
symptoms (B = - 1.30, OR = 0.27, p< .001) had a lower chance of belonging to the “Class 3”
compared to the “Class 2”. Nerve sparing procedure was not able to distinguish between patients
belonging to “Class 2” and “Class 3”. Again, compared to the “Class 2”, the “Class 1” was charac-
terized by patients with lower levels of pre-surgery sexual problems (B = - 0.89, OR = 0.41, p<
.001) and subjected to bilateral nerve sparing RARP (B = 1.19, OR = 3.29, p = .028). Age and uni-
lateral nerve sparing RARP did not distinguish between patients belonging to “Class 2” and
“Class 1”.
Associations between membership in longitudinal trajectories of urinary
incontinence and sexual dysfunction
The results of the Chi-square test assessing the association between memberships in urinary
incontinence and sexual dysfunction membership demonstrated that the two cluster member-
ship tended to co-occur [X2(8, N = 478) = 60.20, p< .001]. Specifically, the adjusted residual
reported in the contingency table (Table 4) demonstrated that patients belonging to the “Class
1” of sexual dysfunction had a low chance to be ascribed to the “Class 4” and “Class 5” and a
high chance to be ascribed to the “Class 1” of urinary incontinence. We highlighted a symmet-
rical and opposite pattern of associations for the “Class 2” of sexual dysfunction; specifically,
patients in this longitudinal trajectory were more likely to be ascribed to “Class 4” and “Class
5” while they had a low likelihood to belong to the “Class 1”. Finally, patients in “Class 3” of
sexual symptoms had a low likelihood to belong to “Class 3” and “Class 4” while showing a
high probability to be ascribed in “Class 1”.
Table 3. Clinical variables in identified sexual clusters.
Clinical Variables Class 1 (%) Class 2 (%) Class 3 (%)
Gleason Score
� 6 55.1 37.6 66.2
7 35.6 44.3 26.8
8 9.3 12.2 7.0
9–10 0 5.9 0
PSA Class
Less than 4 14.4 13.2 8.3
4–10 71.2 63.2 75.0
More than 10 14.4 23.6 16.7
ASA Class
1 22.4 15.8 24.6
2–3 77.6 84.2 75.4
Charlson Index
<1 72.9 69.4 86.1
�1 27.1 30.6 13.9
Complications
No 91.5 87.5 93.1
Yes 8.5 12.5 6.9
https://doi.org/10.1371/journal.pone.0214682.t003
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Discussion
This study identifies different longitudinal trajectories of patients with PC undergone RARP
based on their initial status and change over time in urinary incontinence and sexual
dysfunction.
Different trends for each of these two EPIC-26 subscales were identified: five and three clas-
ses were found for urinary incontinence and sexual dysfunction subscales, respectively. All but
one of the trajectories of urinary incontinence showed a moderate recovery over one year after
surgery. Only the class with the worst initial status showed a non-significant recovery over
time: people who have a high level of urinary incontinence 45 days after surgery are likely to
have a worse recovery. In fact, the small proportion of patients with high urinary incontinence
rates at baseline either do not recover, or their symptomatology gradually decreases over time.
On the contrary, patients with low level of leaking urine after RARP have a faster, and some-
times sudden, recovery. According to the literature [6], these different trends may be affected
by sociodemographic and clinical variables, like age, pre-surgical condition and BMI. Elderly
and overweight patients may display higher level of incontinence 45 days after surgery and
may have more problems in the recovery trajectories, while those with lower levels of pre-sur-
gery continence seem to have greater chance to recover faster and report very small problems
one year after RARP.
Similar to urinary incontinence, sexual dysfunction presents different classes of post-sur-
gery condition and recovery. Patients with low and moderate problems 45 days after surgery
can face a moderate linear recovery, while men with more significant impotence immediately
after surgery may take a longer period to solve sexual dysfunctions. In fact, most of patients
display high level of impotence after RARP and with no recovery of their potency even after
one year from surgery. Age and the pre-surgical sexual condition are important aspects to
identify patients with difficulties in recovery from erectile dysfunction. In fact, elderly men
and patients with sexual impairment before surgery are less likely to recover than the others. A
recent study with a sample stratified by men’s pre-operative scores of erectile function, showed
that each group statistically and differently improved in potency rates at consecutive follow-up
visits up to 24 months, proving that the time of recovery varies along with patients’ baseline
characteristics [31]. Moreover, bilateral nerve-sparing surgical intervention seems to positively
reduce post-surgery recovery.
The evaluation of the association between membership in the longitudinal trajectories of
urinary incontinence and sexual dysfunction may help physicians in the identification of
patients with difficulties in the recovery of both symptoms. In fact, some of these patients
reported both steady problems in sexual function and constant high levels of urinary inconti-
nence over time. On the contrary, people with low rates in urinary incontinence, more proba-
bly will also display less level of sexual potency. Sexual and urinary dysfunctions are the most
Table 4. Contingency table between longitudinal trajectories’ membership of urinary incontinence and sexual dysfunction (adjusted residuals within each cell are
reported in Italics).
Urinary incontinence
Class 1 Class 2 Class 3 Class 4 Class5
Sexual Dysfunction Class 1 56 34 21 6 1
2.2 0.2 0.4 - 2.8 - 2.1
Class 2 81 82 54 52 19
- 5.8 0.3 1.5 4.7 3.2
Class 3 48 18 5 1 0
5.3 - 0.6 - 2.4 - 3.1 - 1.9
https://doi.org/10.1371/journal.pone.0214682.t004
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common consequences after PC treatments [8] and the displayed association underlines the
importance of investigating these aspects in clinical practice. In fact, the scientific literature
shows that sexual life and urinary incontinence are strictly related and the most bothersome
aspects of incontinence were its effects on partner relationship and sexual life [12,15,41].
These results identify urinary incontinence and sexual dysfunction as the most common
and unsolved drawbacks after one year from RARP. Even if they show an overall improvement
over time, one year after RARP no patients’ class has a full recovery and most of the time scores
down only a point in one year. For this reason, it would be important to analyze cancer survi-
vors’ recovery for a longer time in order to better describe the complete process of care
[42,43]. Research studies on short and long side-effects pointed out that patients still suffer
from erectile dysfunction, but have a good continence status, even after a median follow-up of
42 months after surgery [12]. Moreover, physical impairments negatively impact patients’ level
of distress, quality of life and life satisfaction even 2- or 3-years after diagnosis [27,44].
Clinical implications
The identification of different longitudinal trajectories of patients with PC undergone RARP
in urinary incontinence and sexual dysfunction provides new evidences on patients’ recovery
over the care process. These evidences may be important elements to be discussed during
patient-physician relationship: urologists may adopt this information to help men make
informed decisions in line with their individual preference and adjust their expectations about
long-term sexual life. In fact, physicians’ and patients’ hopes of body function recovery do not
always concur and great clarity would be needed [45,46].
Thanks to the adoption of a person-oriented approach, our results may be useful to identify
patients at risk and typical trajectories of recovery, which are important prerequisites of a
patient-centered care and planned healthcare programs. A patient-centered approach related
to a multidisciplinary cooperation would be important to overcome medical barriers and
empower patients, making them aware of their care pathway [47,48]. Along with personalized
interventions and the development of eHealth platforms to enhance patient’s health literacy
and engagement [49–51], a new approach to the healthcare system would be needed. The
implementation of a new healthcare system based on value would help set up predictive and
individualized care pathways for each cancer diagnosis. The patient would be followed along
the care process collecting psychological, medical outcomes and economical outcomes in
order to implement predictive model of care [52–54].
Limitations
Several limitations of this study have to be considered. First of all, we were not able to conduct
a growth mixture modelling (GMM) analysis instead of the LCGA, although a larger sample
would have been necessary to conduct a GMM. In LCGA we set to 0 the intra-class variances
of intercepts and slopes, providing a less accurate estimate of the latent trend of the dysfunc-
tions’ recovery [55]. Moreover, comorbidities and other possible psychological or medical pre-
dictors have not been collected. Finally, the measured outcomes were collected up to only one
year after surgery: it would be important to extend the follow-ups, in order to better analyse
patient’s recovery of functions, which mostly lasts more than one year after treatments [6,27].
Therefore, our future directions would be to collect more information about patient’s char-
acteristics and psychological outcomes through the use of standardized questionnaires and
semi-structured interviews to provide more comprehensive framework of the patient care
process.
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Conclusions
Patients who underwent RARP and followed for one year after surgery showed different trajec-
tories of recovery both in urinary incontinence and in sexual dysfunction. The LCGA identi-
fied three and five different initial medical status and trends of recovery in impotence and
urine leaking, respectively, that were influenced by clinical and sociodemographic predictors
such as age, pre-surgical scores of physical dysfunctions, diabetes and BMI. This study high-
lights different categories of patients at risk who may be important to know in order to develop
personalized medical pathways and predictive models in a value-based healthcare.
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